» Articles » PMID: 25120191

C9orf72 FTLD/ALS-associated Gly-Ala Dipeptide Repeat Proteins Cause Neuronal Toxicity and Unc119 Sequestration

Abstract

Hexanucleotide repeat expansion in C9orf72 is the most common pathogenic mutation in patients with amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration (FTLD). Despite the lack of an ATG start codon, the repeat expansion is translated in all reading frames into dipeptide repeat (DPR) proteins, which form insoluble, ubiquitinated, p62-positive aggregates that are most abundant in the cerebral cortex and cerebellum. To specifically analyze DPR toxicity and aggregation, we expressed DPR proteins from synthetic genes containing a start codon but lacking extensive GGGGCC repeats. Poly-Gly-Ala (GA) formed p62-positive cytoplasmic aggregates, inhibited dendritic arborization and induced apoptosis in primary neurons. Quantitative mass spectrometry analysis to identify poly-GA co-aggregating proteins revealed a significant enrichment of proteins of the ubiquitin-proteasome system. Among the other interacting proteins, we identified the transport factor Unc119, which has been previously linked to neuromuscular and axonal function, as a poly-GA co-aggregating protein. Strikingly, the levels of soluble Unc119 are strongly reduced upon poly-GA expression in neurons, suggesting a loss of function mechanism. Similar to poly-GA expression, Unc119 knockdown inhibits dendritic branching and causes neurotoxicity. Unc119 overexpression partially rescues poly-GA toxicity suggesting that poly-GA expression causes Unc119 loss of function. In C9orf72 patients, Unc119 is detectable in 9.5 % of GA inclusions in the frontal cortex, but only in 1.6 % of GA inclusions in the cerebellum, an area largely spared of neurodegeneration. A fraction of neurons with Unc119 inclusions shows loss of cytosolic staining. Poly-GA-induced Unc119 loss of function may thereby contribute to selective vulnerability of neurons with DPR protein inclusions in the pathogenesis of C9orf72 FTLD/ALS.

Citing Articles

C9orf72-linked arginine-rich dipeptide repeats aggravate pathological phase separation of G3BP1.

Van Nerom M, Ahmed J, Lazar T, Meszaros A, Galand Q, De Malsche W Proc Natl Acad Sci U S A. 2024; 121(50):e2402847121.

PMID: 39621905 PMC: 11648655. DOI: 10.1073/pnas.2402847121.


Pathological Involvement of Protein Phase Separation and Aggregation in Neurodegenerative Diseases.

Wu Y, Ma B, Liu C, Li D, Sui G Int J Mol Sci. 2024; 25(18).

PMID: 39337671 PMC: 11432175. DOI: 10.3390/ijms251810187.


Poly-GP accumulation due to C9orf72 loss of function induces motor neuron apoptosis through autophagy and mitophagy defects.

de Calbiac H, Renault S, Haouy G, Jung V, Roger K, Zhou Q Autophagy. 2024; 20(10):2164-2185.

PMID: 39316747 PMC: 11423671. DOI: 10.1080/15548627.2024.2358736.


Antisense Oligonucleotides (ASOs) in Motor Neuron Diseases: A Road to Cure in Light and Shade.

Cantara S, Simoncelli G, Ricci C Int J Mol Sci. 2024; 25(9).

PMID: 38732027 PMC: 11083842. DOI: 10.3390/ijms25094809.


Hippocampal aggregation signatures of pathogenic UBQLN2 in amyotrophic lateral sclerosis and frontotemporal dementia.

Thumbadoo K, Dieriks B, Murray H, Swanson M, Yoo J, Mehrabi N Brain. 2024; 147(10):3547-3561.

PMID: 38703371 PMC: 11449146. DOI: 10.1093/brain/awae140.


References
1.
Sieben A, Danek A, Martin J, Vandenberghe R, De Deyn P, Corsmit E . A pan-European study of the C9orf72 repeat associated with FTLD: geographic prevalence, genomic instability, and intermediate repeats. Hum Mutat. 2012; 34(2):363-73. PMC: 3638346. DOI: 10.1002/humu.22244. View

2.
Kobayashi A, Higashide T, HAMASAKI D, Kubota S, Sakuma H, An W . HRG4 (UNC119) mutation found in cone-rod dystrophy causes retinal degeneration in a transgenic model. Invest Ophthalmol Vis Sci. 2000; 41(11):3268-77. View

3.
Mann D . C9ORF72: grabbing a tiger by the tail. Acta Neuropathol. 2014; 127(3):311-8. DOI: 10.1007/s00401-014-1252-8. View

4.
Fleck D, van Bebber F, Colombo A, Galante C, Schwenk B, Rabe L . Dual cleavage of neuregulin 1 type III by BACE1 and ADAM17 liberates its EGF-like domain and allows paracrine signaling. J Neurosci. 2013; 33(18):7856-69. PMC: 6618983. DOI: 10.1523/JNEUROSCI.3372-12.2013. View

5.
Josephs K, Hodges J, Snowden J, Mackenzie I, Neumann M, Mann D . Neuropathological background of phenotypical variability in frontotemporal dementia. Acta Neuropathol. 2011; 122(2):137-53. PMC: 3232515. DOI: 10.1007/s00401-011-0839-6. View